Kerri St. Denis - Concepedia

Author

Kerri St. Denis

Ragon Institute of MGH, MIT and Harvard ORCID

Also Known As

K.St. Denis, Kerri J St Denis, Kerri J St. Denis, Kerri J. St Denis, Kerri J. St. Denis, Kerri St. Denis

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

Ragon Institute of MGH, MIT and Harvard Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute Centre for the AIDS Programme of Research in South Africa

About

Kerri St. Denis is an author at Ragon Institute of MGH, MIT and Harvard specializing in immunology, medicine, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	3.1K
2	Immunology	14	15	3.1K
3	Humoral Immunity	7	7	1.7K
4	Epidemiology	3	3	54
5	Allergy	2	2	77

Kerri St. Denis

Publications

Citations

H-Index

Page 1

	Year	Citations
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis, Cell VaccinationMultiple Sars-cov-2 VariantsVaccine DevelopmentImmunologyHumoral Immunity	2021	1.5K
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Wilfredo F. García-Beltrán, Kerri St. Denis, Evan C. Lam, Cell VaccinationSars-cov-2 Omicron VariantVaccine DevelopmentImmunologyVirology	2022	1.1K
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals Vivek Naranbhai, Anusha Nathan, Clarety Kaseke, Cell	2022	253
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Wilfredo F. García-Beltrán, Evan C. Lam, Kerri St. Denis,	2021	214
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant Wilfredo F. García-Beltrán, Kerri St. Denis, Evan C. Lam,	2021	123
Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Naive Nursing Home Residents David H. Canaday, Lenore L. Carias, Oladayo A. Oyebanji, Clinical Infectious Diseases VaccinationVaccine DevelopmentVaccine TargetHealthcare Worker ControlsImmunology	2021	100
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, Nature Communications	2024	71
Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses Jared Feldman, Julia Bals, Clara G. Altomare, Science Immunology Related SarbecovirusesViral EvolutionViral PersistenceAdaptive Immune SystemNaive Antibody	2021	56
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents David H. Canaday, Oladayo A. Oyebanji, Elizabeth M. White, EBioMedicine	2022	49
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children Yannic C. Bartsch, Kerri St. Denis, Paulina Kapłonek, Science Translational Medicine Vaccine ResearchImmunodeficienciesImmunologyImmunodominanceCovid-19	2022	44

Page 1